BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  CanniMed Therapeutics Forms Special Committee for Potential Unsolicited Offer from Aurora Cannabis

  The CanniMed board will review the Proposal, in consultation with their respective legal and financial advisors, and will respond in due course.

  November 22, 2017

   · 

  5 min read
• Tetra Bio-Pharma’s Business Model and Commercialization Strategy in Line With the Canadian Government’s Proposed Approach to the Regulation of Cannabis

  The proposed approach to regulation recommends that cannabis-based health products are still subject to scientific review and must show significant efficacy, meet strict safety requirements and be of sufficient quality in order to gain market approval as a drug or as a natural health product.

  November 22, 2017

   · 

  5 min read
• Genetown

  Analogic Corporation to Webcast Annual Stockholders’ Meeting - Nov. 20, 2017

  Bernard Bailey, chairman of the board for Analogic, will host the meeting.

  November 22, 2017

   · 

  1 min read
• Business

  SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre for Proteomics and Mass Spectrometry Across Asia Pacific

  PPC and SCIEX have established a strong partnership since the inauguration of PPC at NUS Faculty of Science in 2000.

  November 22, 2017

   · 

  5 min read
• Pharm Country

  Quadrant Biosciences Release: Salivary microRNA May Predict Duration and Nature of Concussion Symptoms Among Children

  Small molecules in saliva may hold the key to predicting the type and duration of concussion symptoms, according to a study just published in the JAMA.

  November 22, 2017

   · 

  4 min read
• Alzheimer’s Research UK Release: Autumn Budget Misses Mark for Dementia

  Alzheimer’s Research UK is calling on the government to make continued commitments that support world-class research to address dementia.

  November 22, 2017

   · 

  1 min read
• Business

  Kiwa Bio-Tech Files Restated Financial Statements

  The Amended Annual Report incorporates restated financial statements which properly account for all matters which were the subject of the prior conclusion that the Annual Report should no longer be relied upon.

  November 22, 2017

   · 

  3 min read
• Deals

  Orig3n Acquires Interleukin Genetics, a Genetics-Based Personalized Health Company, to Advance the Future of Health Faster

  The automated genotyping lab is fully-licensed for testing in all 50 U.S. states and is capable of processing over one million samples per year.

  November 22, 2017

   · 

  3 min read
• Policy

  ArisGlobal is First Life Pharmacovigilance Solutions Provider to Successfully Complete Testing With EMA E2B(R3) Import Export Functionality

  Meeting the November 22, 2017 deadline set by EMA will give ArisGlobal’s 200+ customers the peace of mind that they will be fully compliant with EMA’s landmark regulatory requirement.

  November 22, 2017

   · 

  3 min read
• 

  FDA

  FDA OKs RxSight’s Light Adjustable Lens, First IOL to Enable Refractive Correction After Cataract Surgery

  The approval was based on results of a U.S. randomized, pivotal study comparing the Light Adjustable Lens to a commercially available monofocal lens in 600 patients with pre-existing astigmatism.

  November 22, 2017

   · 

  4 min read